Publication | Closed Access

Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial

UrologyMedicineCancer ManagementPharmacologyPharmacotherapyCancer TreatmentProstatic DiseaseFirst-line ChemotherapyOncologyCabadoc Trial